Abstract
A mini-review of the literature concerning epigenetic gene regulation in cancer. © 2000 Cancer Research Campaign http://www.bjcancer.com
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Abdollahi A, Godwin AK, Miller PD, Getts LA, Schultz DC, Taguchi T, Testa JR and Hamilton TC (1997) Identification of a gene containing zinc-finger motifs based on lost expression in malignantly transformed rat ovarian surface epithelial cells. Cancer Res 57: 2029–2034
Antequera F and Bird A (1993) Number of CpG islands and genes in human and mouse. Proc Natl Acad Sci USA 90: 11995–11999
Bachman KE, Herman JG, Corn PG, Merlo A, Costello JF, Cavenee WK, Baylin SB and Graff JR (1999) Methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene suggest a suppressor role in kidney, brain, and other human cancers. Cancer Res 59: 798–802
Batova A, Diccianni MB, Yu JC, Nobori T, Link MP, Pullen J and Yu AL (1997) Frequent and selective methylation of p15 and deletion of both p15 and p16 in T-cell acute lymphoblastic leukemia. Cancer Res 57: 832–836
Bhattacharya SK, Ramchandani S, Cervoni N and Szyf M (1999) A mammalian protein with specific demethylase activity for mCpG DNA. Nature 397: 579–583
Bochar DA, Wang L, Beniya H, Kinev A, Xue Y, Lane WS, Wang W, Kashanchi F and Shiekhattar R (2000) BRCA1 is associated with a human SWI/SNF-related complex: linking chromatin remodeling to breast cancer. Cell 102: 257–265
Brandeis M, Frank D, Keshet I, Siegfried Z, Mendelsohn M, Nemes A, Temper V, Razin A and Cedar H (1994) Sp1 elements protect a CpG island from de novo methylation. Nature 371: 435–438
Brehm A, Miska EA, McCance DJ, Reid JL, Bannister AG and Kouzarides T (1998) Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391: 597–601
Breivik J and Gaudernack G (1999) Carcinogenesis and natural selection: a new perspective to the genetics and epigenetics of colorectal cancer. Adv Cancer Res 76: 187–212
Capaccioli S, Quattrone A, Schiavone N, Calastertti A, Copreni E, Bevilacqua A, Canti G, Gong L, Morelli S and Nicolin A (1996) A bcl-2/IgH antisense transcript deregulates bcl-2 gene expression in human follicular lymphoma t(14;18) cell lines. Oncogene 13: 105–115
Christofori G, Naik P and Hanahan D (1995) Deregulation of both imprinted and expressed alleles of the insulin-like growth factor 2 gene during beta-cell tumorigenesis. Nat Genet 10: 196–201
Cui H, Horon IL, Ohlsson R, Hamilton SR and Feinberg AP (1998) Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability. Nat Med 4: 1276–1280
Dammann R, Li C, Yoon JH, Chin PL, Bates S and Pfeifer GP (2000) Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet 25: 315–319
Eads CA, Danenberg KD, Kawakami K, Saltz LB, Danenberg PV and Laird PW (1999) CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression. Cancer Res 59: 2302–2306
Estellar M, Hamilton SR, Burger PC, Baylin SB and Herman JG (1999) Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res 59: 793–797
Estellar M, Silva JM, Dominguez G, Bonilla F, Matias-Guiu X, Lerma E, Bussaglia E, Prat J, Harkes IC, Repasky EA, Gabrielson E, Schutte M, Baylin SB and Herman JG (2000) Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J Natl Cancer Inst 92: 564–569
Feil R and Khosla S (1999) Genomic imprinting in mammals: An interplay between chromatin and DNA methylation?. Trends Genet 15: 431–435
Feinberg AP (1999) Imprinting of a genomic domain of 11p15 and loss of imprinting in cancer: An introduction. Cancer Res 59: 1743s–1746s
Ferguson AT, Evron E, Umbircht CB, Pandita TK, Chan TA, Hermeking H, Marks JR, Lambers AR, Futreal PA, Stampfer MR and Sukumar S (2000) High frequency of hypermethylation at the 14–3–3 σ locus leads to gene silencing in breast cancer. Proc Natl Acad Sci USA 97: 6049–6054
Gardiner-Garden M and Frommer M (1987) CpG islands in vertebrate genomes. J Mol Biol 196: 261–282
Grady WM, Willis J, Guilford PJ, Dunbier AK, Toro TT, Lynch H, Wiesner G, Ferguson K, Eng C, Park J-G, Kim S-J and Markowitz S (2000) Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat Genet 26: 16–17
Hastie ND (1994) The genetics of Wilms' tumor – a case of disrupted development. Ann Rev Genet 28: 523–558
Herman JG, Latif F, Weng Y, Lerman MI, Zbar B, Liu S, Samid D, Duan DS, Gnarra JR and Linehan WM (1994) Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci USA 91: 9700–9704
Herman JG, Merlo A, Mao L, Lapidus RG, Issa JP, Davidson NE, Sidransky D and Baylin SB (1995) Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 55: 4525–4530
Issa JP, Vertino PM, Wu J, Sazawal S, Celano P, Nelkin BD, Hamilton SR and Baylin SB (1993) Increased cytosine DNA-methyltransferase activity during colon cancer progression. J Natl Cancer Inst 85: 1235–1240
Joyce JA and Schofield PN (1998) Genomic imprinting and cancer. J Clin Pathol Mol Pathol 51: 185–190
Kamiya M, Judson H, Okazaki Y, Kusakabe M, Muramatsu M, Takada S, Takagi N, Arima T, Wake N, Kamimura K, Satomura K, Hermann R, Bonthron DT and Hayashizaki Y (2000) The cell cycle control gene ZAC/PLAGL1 is imprinted – a strong candidate gene for transient neonatal diabetes. Hum Mol Genet 9: 453–460
Kane MF, Loda M, Gadia GM, Lipman J, Mishra R, Goldman H, Jessup JM and Kolodner R (1997) Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumour cell lines. Cancer Res 57: 808–811
Li E (1999) The mojo of methylation. Nature 23: 5–6
Li E, Beard C and Jaenisch R (1993) Role for DNA methylation in genomic imprinting. Nature 366: 362–365
Maher ER and Reik W (2000) Beckwith-Wiedemann syndrome: Imprinting in clusters revisited. J Clin Invest 105: 247–252
Mai M, Qian C, Yokomizo A, Tindall DJ, Bostwick D, Polychronakos C, Smith DI and Liu W (1998) Loss of imprinting and allele switching of p73 in renal cell carcinoma. Oncogene 17: 1739–1741
Malik K, Salpekar A, Hancock A, Moorwood K, Jackson S, Charles A and Brown KW (2000) Identification of differential methylation of the WT1 antisense regulatory region and relaxation of imprinting in Wilms' tumor. Cancer Res 60: 2356–2360
Mancini DN, Rodenhiser DI, Ainsworth PJ, O'Malley FP, Singh SM, Xing W and Archer TK (1998) CpG methylation within the 5′ regulatory region of the BRCA1 gene is tumor specific and includes a putative CREB binding site. Oncogene 16: 1161–1160
Menke AL, Riteco N, vanHam RCA, deBruyne C, Rauscher, III FJ, van der Eb AJ and Jochemsen AG (1996) Wilms' tumor I splice variants have opposite effects on the tumorigenicity of adenovirus-transformed baby-rat kidney cells. Oncogene 12: 537–546
Moorwood K, Charles AK, Salpekar A, Wallace JI, Brown KW and Malik K (1998) Antisense WT1 transcription parallels sense mRNA and protein expression in fetal kidney and can elevate protein levels. in vitro. J Pathol 185: 352–359
Moulton T, Crenshaw T, Hao Y, Moosikasuwan J, Lin N, Dembitzer F, Hensle T, Weiss L, McMorrow L, Loew T, Kraus W, Gerald W and Tycko B (1994) Epigenetic lesions at the H19 locus in Wilms' tumour patients. Nat Genet 7: 440–447
Ohtani-Fujita N, Dryja TP, Rapaport JM, Fujita T, Matsumura S, Ozasa K, Watanabe Y, Hayashi K, Maeda K, Kinoshita S, Matsumura T, Ohnishi Y, Hotta Y, Takahashi R, Kato MV, Ishizaki K, Sasaki MS, Horsthemke B, Minoda K and Sakai T (1997) Hypermethylation in the retinoblastoma gene is associated with unilateral, sporadic retinoblastoma. Cancer Genet Cytogenet 98: 43–49
Okamoto K, Morison IM, Taniguchi T and Reeve AE (1997) Epigenetic changes at the insulin-like growth factor II/H19 locus in developing kidney is an early event in Wilms tumorigenesis. Proc Natl Acad Sci USA 94: 5367–5371
Okano M, Bell DW, Haber DA and Li E (1999) DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99: 247–257
Okutsu T, Kuroiwa Y, Kagitani F, Kai M, Aisaka K, Tsutsumi O, Kaneko Y, Yokomori K, Surani MA, Kohda T, Kaneko-Ishino T and Ishino F (2000) Expression and imprinting status of human PEG8/IGF2AS, a paternally expressed antisense transcript from the IGF2 locus, in Wilms' tumors. J Biochem 127: 475–483
Olek A, Oswald J and Walter J (1996) A modified and improved method for bisulphite based cytosine methylation analysis. Nucelic Acids Res 24: 5064–5066
Rainier S, Johnson LA, Dobry CJ, Ping AJ, Grundy PE and Feinberg AP (1993) Relaxation of imprinted genes in human cancer. Nature 362: 747–749
Raman V, Martensen SA, Reisman D, Evron E, Odenwald WF, Jaffee E, Marks J and Sukumar S (2000) Compromised HOXA5 function can limit p53 expression in human breast tumours. Nature 405: 974–978
Reik W and Murrell A (2000) Silence across the border. Nature 405: 408–409
Reik W and Surani A (1989) Genomic imprinting and embryonal tumours. Nature 338: 112–113
Rhee I, Jair K-W, Chiu Yen R-W, Lengauer C, Herman JG, Kinzler KW, Vogelstein B, Baylin SB and Schuebel KE (2000) CpG methylation is maintained in human cancer cells lacking DNMT1. Nature 404: 1003–1007
Robertson KD, Uzvolgyi E, Liang G, Talmadge C, Sumegi J, Gonzales FA and Jones PA (1999) The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res 27: 2291–2298
Schwienbacher C, Angioni A, Scelfo R, Veronese A, Calin GA, Massazza G, Hatada I, Barbanti-Brodano G and Negrini M (2000) Abnormal RNA expression of 11p 15 imprinted genes and kidney developmental genes in Wilms' tumor. Cancer Res 60: 1521–1525
Sullivan MJ, Taniguchi T, Jhee A, Kerr N and Reeve AE (1999) Relaxation of IGF2 imprinting in Wilms tumours associated with specific changes in IGF2 methylation. Oncogene 18: 7527–7534
Teitz T, Wei T, Valentine MB, Vanin EF, Grenet J, Valentine VA, Behm FG, Look At, Lahti JM and Kidd VJ (2000) Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. Nat Med 6: 529–535
Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB and Issa JP (1999) CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA 96: 8681–8686
Toyota M, Shen L, Ohe-Toyota M, Hamilton SR, Sinicrope FA and Issa JJ (2000) Aberrant methylation of the cyclooxygenase 2 CpG island in colorectal tumours. Cancer Res 60: 4044–4048
Varrault A, Ciani E, Apiou F, Bilanges B, Hoffmann A, Pantaloni C, Bockaert J, Spengler D and Journot L (1998) hZAC encodes a zinc finger protein with antiproliferative properties and maps to a chromosomal region frequently lost in cancer. Proc Natl Acad Sci USA 95: 8835–8840
Weksberg R, Shen DR, Fei YL, Song QL and Squire J (1993) Disruption of insulin-like growth factor 2 imprinting in Beckwith-Wiedemann syndrome. Nat Genet 5: 143–150
Wutz A, Smrzka OW, Schweifer N, Schellander K, Wagner EF and Barlow DP (1997) Imprinted expression of the Igf2r gene depends on an intronic CpG island. Nature 389: 745–749
Yu Y, Xu F, Peng H, Fang X, Zhao S, Li Y, Cuevas B, Kuo W-L, Gray JW, Siciliano M, Mills GB and Bast RC, Jr (1999) NOEY2 (ARHI), an imprinted putative tumor supressor gene in ovarian and breast carcinomas. Proc Natl Acad Sci USA 96: 214–219
Xu F, Xia W, Luo RZ, Peng H, Zhao S, Dai J, Long Y, Zou L Le W, Liu J, Parlow AF, Hung M, Bast RC and Yu Y (2000) The human ARHI tumor suppressor gene inhibits lactation and growth in transgenic mice. Cancer Res 60: 4913–4920
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Malik, K., Brown, K. Epigenetic gene deregulation in cancer. Br J Cancer 83, 1583–1588 (2000). https://doi.org/10.1054/bjoc.2000.1549
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2000.1549
Keywords
This article is cited by
-
Cytoglobin: biochemical, functional and clinical perspective of the newest member of the globin family
Cellular and Molecular Life Sciences (2011)
-
DNA methylation in cancer: too much, but also too little
Oncogene (2002)
-
Gli and hedgehog in cancer: tumours, embryos and stem cells
Nature Reviews Cancer (2002)